2018-2023 Global Brucellosis Vaccines Consumption Market Report
- LP 2660891
- 165 Pages
- August 2018
- Pharmaceuticals
Brucellosis vaccine is a vaccine for cattle, sheep and goats used against brucellosis. Currently, there is no vaccine available for humans.
The classification of Brucellosis Vaccines includes S19 Vaccine, RB51 Vaccine Strain and Other. And the proportion of S19 Vaccine in 2016 is about 86%, and the proportion is stable from 2012 to 2016.
Brucellosis Vaccines is widely used in Cattle, Sheep and Other Animal. The most proportion of Brucellosis Vaccines is for Cattle with market share about 60 in 2016.
China is the largest supplier of Brucellosis Vaccines, with a production market share nearly 31% in 2016. Europe is the second largest supplier of Brucellosis Vaccines, enjoying production market share nearly 17% in 2016.
China is the largest consumption place, with a consumption market share nearly 31% in 2016. Following China, South America is the second largest consumption place with the consumption market share of 17%.
Over the next five years, LPI(LP Information) projects that Brucellosis Vaccines will register a 3.8% CAGR in terms of revenue, reach US$ 12 million by 2023, from US$ 10 million in 2017.
This report presents a comprehensive overview, market shares, and growth opportunities of Brucellosis Vaccines market by product type, application, key manufacturers and key regions.
To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:
Segmentation by product type:
S19 Vaccine
RB51 Vaccine Strain
Other
Segmentation by application:
Cattle
Sheep
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
Jinyu
Colorado Serum
Boehringer Ingelheim
Biogenesis-Bago
Vetal Company
CZ Veterinaria
SYVA Laboratorios
Indian Immunologicals
Qilu
Tecnovax
Hester Biosciences
Zoetis
Onderstepoort Biological
Instituto Rosenbusch
Ceva Sante Animale
Calier & Biologicos Laverlam
Biovet
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Brucellosis Vaccines consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Brucellosis Vaccines market by identifying its various subsegments.
Focuses on the key global Brucellosis Vaccines manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Brucellosis Vaccines with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Brucellosis Vaccines submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
2018-2023 Global Brucellosis Vaccines Consumption Market Report
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Brucellosis Vaccines Consumption 2013-2023
2.1.2 Brucellosis Vaccines Consumption CAGR by Region
2.2 Brucellosis Vaccines Segment by Type
2.2.1 S19 Vaccine
2.2.2 RB51 Vaccine Strain
2.2.3 Other
2.3 Brucellosis Vaccines Consumption by Type
2.3.1 Global Brucellosis Vaccines Consumption Market Share by Type (2013-2018)
2.3.2 Global Brucellosis Vaccines Revenue and Market Share by Type (2013-2018)
2.3.3 Global Brucellosis Vaccines Sale Price by Type (2013-2018)
2.4 Brucellosis Vaccines Segment by Application
2.4.1 Cattle
2.4.2 Sheep
2.4.3 Other
2.5 Brucellosis Vaccines Consumption by Application
2.5.1 Global Brucellosis Vaccines Consumption Market Share by Application (2013-2018)
2.5.2 Global Brucellosis Vaccines Value and Market Share by Application (2013-2018)
2.5.3 Global Brucellosis Vaccines Sale Price by Application (2013-2018)
3 Global Brucellosis Vaccines by Players
3.1 Global Brucellosis Vaccines Sales Market Share by Players
3.1.1 Global Brucellosis Vaccines Sales by Players (2016-2018)
3.1.2 Global Brucellosis Vaccines Sales Market Share by Players (2016-2018)
3.2 Global Brucellosis Vaccines Revenue Market Share by Players
3.2.1 Global Brucellosis Vaccines Revenue by Players (2016-2018)
3.2.2 Global Brucellosis Vaccines Revenue Market Share by Players (2016-2018)
3.3 Global Brucellosis Vaccines Sale Price by Players
3.4 Global Brucellosis Vaccines Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Brucellosis Vaccines Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Brucellosis Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Brucellosis Vaccines by Regions
4.1 Brucellosis Vaccines by Regions
4.1.1 Global Brucellosis Vaccines Consumption by Regions
4.1.2 Global Brucellosis Vaccines Value by Regions
4.2 Americas Brucellosis Vaccines Consumption Growth
4.3 APAC Brucellosis Vaccines Consumption Growth
4.4 Europe Brucellosis Vaccines Consumption Growth
4.5 Middle East & Africa Brucellosis Vaccines Consumption Growth
5 Americas
5.1 Americas Brucellosis Vaccines Consumption by Countries
5.1.1 Americas Brucellosis Vaccines Consumption by Countries (2013-2018)
5.1.2 Americas Brucellosis Vaccines Value by Countries (2013-2018)
5.2 Americas Brucellosis Vaccines Consumption by Type
5.3 Americas Brucellosis Vaccines Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Brucellosis Vaccines Consumption by Countries
6.1.1 APAC Brucellosis Vaccines Consumption by Countries (2013-2018)
6.1.2 APAC Brucellosis Vaccines Value by Countries (2013-2018)
6.2 APAC Brucellosis Vaccines Consumption by Type
6.3 APAC Brucellosis Vaccines Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Brucellosis Vaccines by Countries
7.1.1 Europe Brucellosis Vaccines Consumption by Countries (2013-2018)
7.1.2 Europe Brucellosis Vaccines Value by Countries (2013-2018)
7.2 Europe Brucellosis Vaccines Consumption by Type
7.3 Europe Brucellosis Vaccines Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Brucellosis Vaccines by Countries
8.1.1 Middle East & Africa Brucellosis Vaccines Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Brucellosis Vaccines Value by Countries (2013-2018)
8.2 Middle East & Africa Brucellosis Vaccines Consumption by Type
8.3 Middle East & Africa Brucellosis Vaccines Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Brucellosis Vaccines Distributors
10.3 Brucellosis Vaccines Customer
11 Global Brucellosis Vaccines Market Forecast
11.1 Global Brucellosis Vaccines Consumption Forecast (2018-2023)
11.2 Global Brucellosis Vaccines Forecast by Regions
11.2.1 Global Brucellosis Vaccines Forecast by Regions (2018-2023)
11.2.2 Global Brucellosis Vaccines Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Brucellosis Vaccines Forecast by Type
11.8 Global Brucellosis Vaccines Forecast by Application
12 Key Players Analysis
12.1 Jinyu
12.1.1 Company Details
12.1.2 Brucellosis Vaccines Product Offered
12.1.3 Jinyu Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 Jinyu News
12.2 Colorado Serum
12.2.1 Company Details
12.2.2 Brucellosis Vaccines Product Offered
12.2.3 Colorado Serum Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 Colorado Serum News
12.3 Boehringer Ingelheim
12.3.1 Company Details
12.3.2 Brucellosis Vaccines Product Offered
12.3.3 Boehringer Ingelheim Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Boehringer Ingelheim News
12.4 Biogenesis-Bago
12.4.1 Company Details
12.4.2 Brucellosis Vaccines Product Offered
12.4.3 Biogenesis-Bago Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Biogenesis-Bago News
12.5 Vetal Company
12.5.1 Company Details
12.5.2 Brucellosis Vaccines Product Offered
12.5.3 Vetal Company Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 Vetal Company News
12.6 CZ Veterinaria
12.6.1 Company Details
12.6.2 Brucellosis Vaccines Product Offered
12.6.3 CZ Veterinaria Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 CZ Veterinaria News
12.7 SYVA Laboratorios
12.7.1 Company Details
12.7.2 Brucellosis Vaccines Product Offered
12.7.3 SYVA Laboratorios Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 SYVA Laboratorios News
12.8 Indian Immunologicals
12.8.1 Company Details
12.8.2 Brucellosis Vaccines Product Offered
12.8.3 Indian Immunologicals Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 Indian Immunologicals News
12.9 Qilu
12.9.1 Company Details
12.9.2 Brucellosis Vaccines Product Offered
12.9.3 Qilu Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.9.4 Main Business Overview
12.9.5 Qilu News
12.10 Tecnovax
12.10.1 Company Details
12.10.2 Brucellosis Vaccines Product Offered
12.10.3 Tecnovax Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.10.4 Main Business Overview
12.10.5 Tecnovax News
12.11 Hester Biosciences
12.12 Zoetis
12.13 Onderstepoort Biological
12.14 Instituto Rosenbusch
12.15 Ceva Sante Animale
12.16 Calier & Biologicos Laverlam
12.17 Biovet
13 Research Findings and Conclusion
Figure Picture of Brucellosis Vaccines
Table Product Specifications of Brucellosis Vaccines
Figure Brucellosis Vaccines Report Years Considered
Figure Market Research Methodology
Figure Global Brucellosis Vaccines Consumption Growth Rate 2013-2023 (M Doses)
Figure Global Brucellosis Vaccines Value Growth Rate 2013-2023 ($ Millions)
Table Brucellosis Vaccines Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of S19 Vaccine
Table Major Players of S19 Vaccine
Figure Product Picture of RB51 Vaccine Strain
Table Major Players of RB51 Vaccine Strain
Figure Product Picture of Other
Table Major Players of Other
Table Global Consumption Sales by Type (2013-2018)
Table Global Brucellosis Vaccines Consumption Market Share by Type (2013-2018)
Figure Global Brucellosis Vaccines Consumption Market Share by Type (2013-2018)
Table Global Brucellosis Vaccines Revenue by Type (2013-2018) ($ million)
Table Global Brucellosis Vaccines Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Brucellosis Vaccines Value Market Share by Type (2013-2018)
Table Global Brucellosis Vaccines Sale Price by Type (2013-2018)
Figure Brucellosis Vaccines Consumed in Cattle
Figure Global Brucellosis Vaccines Market: Cattle (2013-2018) (M Doses)
Figure Global Brucellosis Vaccines Market: Cattle (2013-2018) ($ Millions)
Figure Global Cattle YoY Growth ($ Millions)
Figure Brucellosis Vaccines Consumed in Sheep
Figure Global Brucellosis Vaccines Market: Sheep (2013-2018) (M Doses)
Figure Global Brucellosis Vaccines Market: Sheep (2013-2018) ($ Millions)
Figure Global Sheep YoY Growth ($ Millions)
Figure Brucellosis Vaccines Consumed in Other
Figure Global Brucellosis Vaccines Market: Other (2013-2018) (M Doses)
Figure Global Brucellosis Vaccines Market: Other (2013-2018) ($ Millions)
Figure Global Other YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Brucellosis Vaccines Consumption Market Share by Application (2013-2018)
Figure Global Brucellosis Vaccines Consumption Market Share by Application (2013-2018)
Table Global Brucellosis Vaccines Value by Application (2013-2018)
Table Global Brucellosis Vaccines Value Market Share by Application (2013-2018)
Figure Global Brucellosis Vaccines Value Market Share by Application (2013-2018)
Table Global Brucellosis Vaccines Sale Price by Application (2013-2018)
Table Global Brucellosis Vaccines Sales by Players (2016-2018) (M Doses)
Table Global Brucellosis Vaccines Sales Market Share by Players (2016-2018)
Figure Global Brucellosis Vaccines Sales Market Share by Players in 2016
Figure Global Brucellosis Vaccines Sales Market Share by Players in 2017
Table Global Brucellosis Vaccines Revenue by Players (2016-2018) ($ Millions)
Table Global Brucellosis Vaccines Revenue Market Share by Players (2016-2018)
Figure Global Brucellosis Vaccines Revenue Market Share by Players in 2016
Figure Global Brucellosis Vaccines Revenue Market Share by Players in 2017
Table Global Brucellosis Vaccines Sale Price by Players (2016-2018)
Figure Global Brucellosis Vaccines Sale Price by Players in 2017
Table Global Brucellosis Vaccines Manufacturing Base Distribution and Sales Area by Players
Table Players Brucellosis Vaccines Products Offered
Table Brucellosis Vaccines Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Brucellosis Vaccines Consumption by Regions 2013-2018 (M Doses)
Table Global Brucellosis Vaccines Consumption Market Share by Regions 2013-2018
Figure Global Brucellosis Vaccines Consumption Market Share by Regions 2013-2018
Table Global Brucellosis Vaccines Value by Regions 2013-2018 ($ Millions)
Table Global Brucellosis Vaccines Value Market Share by Regions 2013-2018
Figure Global Brucellosis Vaccines Value Market Share by Regions 2013-2018
Figure Americas Brucellosis Vaccines Consumption 2013-2018 (M Doses)
Figure Americas Brucellosis Vaccines Value 2013-2018 ($ Millions)
Figure APAC Brucellosis Vaccines Consumption 2013-2018 (M Doses)
Figure APAC Brucellosis Vaccines Value 2013-2018 ($ Millions)
Figure Europe Brucellosis Vaccines Consumption 2013-2018 (M Doses)
Figure Europe Brucellosis Vaccines Value 2013-2018 ($ Millions)
Figure Middle East & Africa Brucellosis Vaccines Consumption 2013-2018 (M Doses)
Figure Middle East & Africa Brucellosis Vaccines Value 2013-2018 ($ Millions)
Table Americas Brucellosis Vaccines Consumption by Countries (2013-2018) (M Doses)
Table Americas Brucellosis Vaccines Consumption Market Share by Countries (2013-2018)
Figure Americas Brucellosis Vaccines Consumption Market Share by Countries in 2017
Table Americas Brucellosis Vaccines Value by Countries (2013-2018) ($ Millions)
Table Americas Brucellosis Vaccines Value Market Share by Countries (2013-2018)
Figure Americas Brucellosis Vaccines Value Market Share by Countries in 2017
Table Americas Brucellosis Vaccines Consumption by Type (2013-2018) (M Doses)
Table Americas Brucellosis Vaccines Consumption Market Share by Type (2013-2018)
Figure Americas Brucellosis Vaccines Consumption Market Share by Type in 2017
Table Americas Brucellosis Vaccines Consumption by Application (2013-2018) (M Doses)
Table Americas Brucellosis Vaccines Consumption Market Share by Application (2013-2018)
Figure Americas Brucellosis Vaccines Consumption Market Share by Application in 2017
Figure United States Brucellosis Vaccines Consumption Growth 2013-2018 (M Doses)
Figure United States Brucellosis Vaccines Value Growth 2013-2018 ($ Millions)
Figure Canada Brucellosis Vaccines Consumption Growth 2013-2018 (M Doses)
Figure Canada Brucellosis Vaccines Value Growth 2013-2018 ($ Millions)
Figure Mexico Brucellosis Vaccines Consumption Growth 2013-2018 (M Doses)
Figure Mexico Brucellosis Vaccines Value Growth 2013-2018 ($ Millions)
Table APAC Brucellosis Vaccines Consumption by Countries (2013-2018) (M Doses)
Table APAC Brucellosis Vaccines Consumption Market Share by Countries (2013-2018)
Figure APAC Brucellosis Vaccines Consumption Market Share by Countries in 2017
Table APAC Brucellosis Vaccines Value by Countries (2013-2018) ($ Millions)
Table APAC Brucellosis Vaccines Value Market Share by Countries (2013-2018)
Figure APAC Brucellosis Vaccines Value Market Share by Countries in 2017
Table APAC Brucellosis Vaccines Consumption by Type (2013-2018) (M Doses)
Table APAC Brucellosis Vaccines Consumption Market Share by Type (2013-2018)
Figure APAC Brucellosis Vaccines Consumption Market Share by Type in 2017
Table APAC Brucellosis Vaccines Consumption by Application (2013-2018) (M Doses)
Table APAC Brucellosis Vaccines Consumption Market Share by Application (2013-2018)
Figure APAC Brucellosis Vaccines Consumption Market Share by Application in 2017
Figure China Brucellosis Vaccines Consumption Growth 2013-2018 (M Doses)
Figure China Brucellosis Vaccines Value Growth 2013-2018 ($ Millions)
Figure Japan Brucellosis Vaccines Consumption Growth 2013-2018 (M Doses)
Figure Japan Brucellosis Vaccines Value Growth 2013-2018 ($ Millions)
Figure Korea Brucellosis Vaccines Consumption Growth 2013-2018 (M Doses)
Figure Korea Brucellosis Vaccines Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Brucellosis Vaccines Consumption Growth 2013-2018 (M Doses)
Figure Southeast Asia Brucellosis Vaccines Value Growth 2013-2018 ($ Millions)
Figure India Brucellosis Vaccines Consumption Growth 2013-2018 (M Doses)
Figure India Brucellosis Vaccines Value Growth 2013-2018 ($ Millions)
Figure Australia Brucellosis Vaccines Consumption Growth 2013-2018 (M Doses)
Figure Australia Brucellosis Vaccines Value Growth 2013-2018 ($ Millions)
Table Europe Brucellosis Vaccines Consumption by Countries (2013-2018) (M Doses)
Table Europe Brucellosis Vaccines Consumption Market Share by Countries (2013-2018)
Figure Europe Brucellosis Vaccines Consumption Market Share by Countries in 2017
Table Europe Brucellosis Vaccines Value by Countries (2013-2018) ($ Millions)
Table Europe Brucellosis Vaccines Value Market Share by Countries (2013-2018)
Figure Europe Brucellosis Vaccines Value Market Share by Countries in 2017
Table Europe Brucellosis Vaccines Consumption by Type (2013-2018) (M Doses)
Table Europe Brucellosis Vaccines Consumption Market Share by Type (2013-2018)
Figure Europe Brucellosis Vaccines Consumption Market Share by Type in 2017
Table Europe Brucellosis Vaccines Consumption by Application (2013-2018) (M Doses)
Table Europe Brucellosis Vaccines Consumption Market Share by Application (2013-2018)
Figure Europe Brucellosis Vaccines Consumption Market Share by Application in 2017
Figure Germany Brucellosis Vaccines Consumption Growth 2013-2018 (M Doses)
Figure Germany Brucellosis Vaccines Value Growth 2013-2018 ($ Millions)
Figure France Brucellosis Vaccines Consumption Growth 2013-2018 (M Doses)
Figure France Brucellosis Vaccines Value Growth 2013-2018 ($ Millions)
Figure UK Brucellosis Vaccines Consumption Growth 2013-2018 (M Doses)
Figure UK Brucellosis Vaccines Value Growth 2013-2018 ($ Millions)
Figure Italy Brucellosis Vaccines Consumption Growth 2013-2018 (M Doses)
Figure Italy Brucellosis Vaccines Value Growth 2013-2018 ($ Millions)
Figure Russia Brucellosis Vaccines Consumption Growth 2013-2018 (M Doses)
Figure Russia Brucellosis Vaccines Value Growth 2013-2018 ($ Millions)
Figure Spain Brucellosis Vaccines Consumption Growth 2013-2018 (M Doses)
Figure Spain Brucellosis Vaccines Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Brucellosis Vaccines Consumption by Countries (2013-2018) (M Doses)
Table Middle East & Africa Brucellosis Vaccines Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Brucellosis Vaccines Consumption Market Share by Countries in 2017
Table Middle East & Africa Brucellosis Vaccines Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Brucellosis Vaccines Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Brucellosis Vaccines Value Market Share by Countries in 2017
Table Middle East & Africa Brucellosis Vaccines Consumption by Type (2013-2018) (M Doses)
Table Middle East & Africa Brucellosis Vaccines Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Brucellosis Vaccines Consumption Market Share by Type in 2017
Table Middle East & Africa Brucellosis Vaccines Consumption by Application (2013-2018) (M Doses)
Table Middle East & Africa Brucellosis Vaccines Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Brucellosis Vaccines Consumption Market Share by Application in 2017
Figure Egypt Brucellosis Vaccines Consumption Growth 2013-2018 (M Doses)
Figure Egypt Brucellosis Vaccines Value Growth 2013-2018 ($ Millions)
Figure South Africa Brucellosis Vaccines Consumption Growth 2013-2018 (M Doses)
Figure South Africa Brucellosis Vaccines Value Growth 2013-2018 ($ Millions)
Figure Israel Brucellosis Vaccines Consumption Growth 2013-2018 (M Doses)
Figure Israel Brucellosis Vaccines Value Growth 2013-2018 ($ Millions)
Figure Turkey Brucellosis Vaccines Consumption Growth 2013-2018 (M Doses)
Figure Turkey Brucellosis Vaccines Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Brucellosis Vaccines Consumption Growth 2013-2018 (M Doses)
Figure GCC Countries Brucellosis Vaccines Value Growth 2013-2018 ($ Millions)
Table Brucellosis Vaccines Distributors List
Table Brucellosis Vaccines Customer List
Figure Global Brucellosis Vaccines Consumption Growth Rate Forecast (2018-2023) (M Doses)
Figure Global Brucellosis Vaccines Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Brucellosis Vaccines Consumption Forecast by Countries (2018-2023) (M Doses)
Table Global Brucellosis Vaccines Consumption Market Forecast by Regions
Table Global Brucellosis Vaccines Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Brucellosis Vaccines Value Market Share Forecast by Regions
Figure Americas Brucellosis Vaccines Consumption 2018-2023 (M Doses)
Figure Americas Brucellosis Vaccines Value 2018-2023 ($ Millions)
Figure APAC Brucellosis Vaccines Consumption 2018-2023 (M Doses)
Figure APAC Brucellosis Vaccines Value 2018-2023 ($ Millions)
Figure Europe Brucellosis Vaccines Consumption 2018-2023 (M Doses)
Figure Europe Brucellosis Vaccines Value 2018-2023 ($ Millions)
Figure Middle East & Africa Brucellosis Vaccines Consumption 2018-2023 (M Doses)
Figure Middle East & Africa Brucellosis Vaccines Value 2018-2023 ($ Millions)
Figure United States Brucellosis Vaccines Consumption 2018-2023 (M Doses)
Figure United States Brucellosis Vaccines Value 2018-2023 ($ Millions)
Figure Canada Brucellosis Vaccines Consumption 2018-2023 (M Doses)
Figure Canada Brucellosis Vaccines Value 2018-2023 ($ Millions)
Figure Mexico Brucellosis Vaccines Consumption 2018-2023 (M Doses)
Figure Mexico Brucellosis Vaccines Value 2018-2023 ($ Millions)
Figure Brazil Brucellosis Vaccines Consumption 2018-2023 (M Doses)
Figure Brazil Brucellosis Vaccines Value 2018-2023 ($ Millions)
Figure China Brucellosis Vaccines Consumption 2018-2023 (M Doses)
Figure China Brucellosis Vaccines Value 2018-2023 ($ Millions)
Figure Japan Brucellosis Vaccines Consumption 2018-2023 (M Doses)
Figure Japan Brucellosis Vaccines Value 2018-2023 ($ Millions)
Figure Korea Brucellosis Vaccines Consumption 2018-2023 (M Doses)
Figure Korea Brucellosis Vaccines Value 2018-2023 ($ Millions)
Figure Southeast Asia Brucellosis Vaccines Consumption 2018-2023 (M Doses)
Figure Southeast Asia Brucellosis Vaccines Value 2018-2023 ($ Millions)
Figure India Brucellosis Vaccines Consumption 2018-2023 (M Doses)
Figure India Brucellosis Vaccines Value 2018-2023 ($ Millions)
Figure Australia Brucellosis Vaccines Consumption 2018-2023 (M Doses)
Figure Australia Brucellosis Vaccines Value 2018-2023 ($ Millions)
Figure Germany Brucellosis Vaccines Consumption 2018-2023 (M Doses)
Figure Germany Brucellosis Vaccines Value 2018-2023 ($ Millions)
Figure France Brucellosis Vaccines Consumption 2018-2023 (M Doses)
Figure France Brucellosis Vaccines Value 2018-2023 ($ Millions)
Figure UK Brucellosis Vaccines Consumption 2018-2023 (M Doses)
Figure UK Brucellosis Vaccines Value 2018-2023 ($ Millions)
Figure Italy Brucellosis Vaccines Consumption 2018-2023 (M Doses)
Figure Italy Brucellosis Vaccines Value 2018-2023 ($ Millions)
Figure Russia Brucellosis Vaccines Consumption 2018-2023 (M Doses)
Figure Russia Brucellosis Vaccines Value 2018-2023 ($ Millions)
Figure Spain Brucellosis Vaccines Consumption 2018-2023 (M Doses)
Figure Spain Brucellosis Vaccines Value 2018-2023 ($ Millions)
Figure Egypt Brucellosis Vaccines Consumption 2018-2023 (M Doses)
Figure Egypt Brucellosis Vaccines Value 2018-2023 ($ Millions)
Figure South Africa Brucellosis Vaccines Consumption 2018-2023 (M Doses)
Figure South Africa Brucellosis Vaccines Value 2018-2023 ($ Millions)
Figure Israel Brucellosis Vaccines Consumption 2018-2023 (M Doses)
Figure Israel Brucellosis Vaccines Value 2018-2023 ($ Millions)
Figure Turkey Brucellosis Vaccines Consumption 2018-2023 (M Doses)
Figure Turkey Brucellosis Vaccines Value 2018-2023 ($ Millions)
Figure GCC Countries Brucellosis Vaccines Consumption 2018-2023 (M Doses)
Figure GCC Countries Brucellosis Vaccines Value 2018-2023 ($ Millions)
Table Global Brucellosis Vaccines Consumption Forecast by Type (2018-2023) (M Doses)
Table Global Brucellosis Vaccines Consumption Market Share Forecast by Type (2018-2023)
Table Global Brucellosis Vaccines Value Forecast by Type (2018-2023) ($ Millions)
Table Global Brucellosis Vaccines Value Market Share Forecast by Type (2018-2023)
Table Global Brucellosis Vaccines Consumption Forecast by Application (2018-2023) (M Doses)
Table Global Brucellosis Vaccines Consumption Market Share Forecast by Application (2018-2023)
Table Global Brucellosis Vaccines Value Forecast by Application (2018-2023) ($ Millions)
Table Global Brucellosis Vaccines Value Market Share Forecast by Application (2018-2023)
Table Jinyu Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Jinyu Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Jinyu Brucellosis Vaccines Market Share (2016-2018)
Table Colorado Serum Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Colorado Serum Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Colorado Serum Brucellosis Vaccines Market Share (2016-2018)
Table Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Boehringer Ingelheim Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Boehringer Ingelheim Brucellosis Vaccines Market Share (2016-2018)
Table Biogenesis-Bago Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Biogenesis-Bago Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Biogenesis-Bago Brucellosis Vaccines Market Share (2016-2018)
Table Vetal Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Vetal Company Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Vetal Company Brucellosis Vaccines Market Share (2016-2018)
Table CZ Veterinaria Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CZ Veterinaria Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
Figure CZ Veterinaria Brucellosis Vaccines Market Share (2016-2018)
Table SYVA Laboratorios Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table SYVA Laboratorios Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
Figure SYVA Laboratorios Brucellosis Vaccines Market Share (2016-2018)
Table Indian Immunologicals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Indian Immunologicals Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Indian Immunologicals Brucellosis Vaccines Market Share (2016-2018)
Table Qilu Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Qilu Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Qilu Brucellosis Vaccines Market Share (2016-2018)
Table Tecnovax Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Tecnovax Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Tecnovax Brucellosis Vaccines Market Share (2016-2018)
Table Hester Biosciences Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Zoetis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Onderstepoort Biological Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Instituto Rosenbusch Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Ceva Sante Animale Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Calier & Biologicos Laverlam Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Biovet Basic Information, Manufacturing Base, Sales Area and Its Competitors
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
